Cumberland pulls lots of particulate-plagued liver drug

Just as the year marches to its inevitable end, we have yet another particle-related recall to add to 2010's tally. Cumberland Pharmaceuticals is pulling six lots of its injectable liver drug, Acetadote, because some vials contained fine particles. The recall is precautionary rather than prompted by adverse-event reports.

Cumberland says the particles' source was the glass vial used by a former packaging supplier. And the company is far from the only one to suffer recently from tiny glass flakes or particles in injectable products. Other sorts of particles have plagued drugmakers from Johnson & Johnson to Amgen.

- read the Reuters news

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.